[ad_1]
Live pandemic
Spahn expects first corona vaccines in December
| Reading time: 2 minutes
The first German citizens could be vaccinated against the coronavirus this year. Health Minister Spahn takes this on. He announced the establishment of an online platform with information on the vaccination rates achieved. All developments on the live ticker.
secondUnwealth Minister Jens Spahn (CDU) assumes that the first German citizens can be immunized against the coronavirus at vaccination centers this year. “There is reason to be optimistic about the approval of a vaccine in Europe this year. And then we can immediately start vaccines, ”Spahn told the German publishing network (RND / Monday numbers).
He called on the federal states for the vaccination centers to be ready for use by mid-December, the minister said. This seems to be working. I would rather have a vaccination center that is ready to go and out of service for a few days than an approved vaccine that is not used immediately, Spahn said.
Spahn was also optimistic that it would not take until the end of 2021 for all population groups to be vaccinated. For example, many of the possible vaccines will not require deep cooling. They could be issued in normal doctor’s offices.
“And then it’s fast,” Spahn said. After all, “each year, up to 20 million people would be vaccinated against the flu in a few weeks.” He announced the establishment of an online platform that provides information on the vaccination rates achieved, differentiated by age and region. “In particular, when we have achieved a high vaccination rate among particularly vulnerable population groups, we can gradually relax the restrictions,” he announced.
According to Spahn, Germany has secured more than 300 million doses of vaccines for Germany through the EU Commission or through bilateral agreements and options. “Even with two doses per vaccination, we would have enough for our own population and we could share it with other countries,” Spahn said.
The minister announced that Germany would also secure the vaccination doses from the Dessau vaccine manufacturer IDT. “From today’s perspective, there is well-founded hope that the Dessau IDT can also get approval for a vaccine in 2021,” he said before a visit to the company on Monday. It is “very encouraging and can make us proud that, after Biontech and Curevac, the third German vaccine project is on a promising path,” Spahn said.